Company intelligence / Profile preview

Zhanjiang Bokang Marine Biological

Zhanjiang, Guangdong, Chinaaccumedi.com ↗

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Zhanjiang Bokang Marine Biological was the first company in China to manufacture endotoxin assay kits (TAL) and remains a top-three producer. Their products are ISO standard with CE marking, widely used for quality control testing of pharmaceuticals, biologics, radioactive medicines, and medical devices. The company collaborates with regulatory authorities such as the CFDA on standards development and training. No clinical trial results as their products are diagnostics for industrial QC.

Therapeutic areas: Other
Modalities: Diagnostic kit (Endotoxin assay kits, specifically TAL—Tachypleus Amebocyte Lysate)
Industry: Chemicals & Materials

Partnerships

China Food and Drug Administration (CFDA) – collaboration on standards/training

Beyond the preview

Go deeper on Zhanjiang Bokang Marine Biological.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhanjiang Bokang Marine Biological.

Explore the full profile